CCP
DARE icon

Clough Capital Partners’s Dare Bioscience DARE Stock Holding History

Clough Capital Partners’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-2,303
Closed -$1.27M – 202
2015
Q2 		$1.27M Buy
+2,303
New +$1.58M 0.05% 139

Other funds holding DARE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Clough Capital Partners's DARE Position: Q3 2015 in Review

Clough Capital Partners sold out of Dare Bioscience (DARE) in Q3 2015, closing a stake of 2,303 shares — an estimated $1.27M sold.

Clough Capital Partners first reported a position in DARE in Q2 2015 and held it in 1 quarter. The position peaked at $1.27M in Q2 2015. 38 funds tracked by Wall St. Rank hold DARE as of Q3 2015.

  • Clough Capital Partners reported no remaining Dare Bioscience position as of Q3 2015 after selling out during the quarter.
  • Clough Capital Partners sold 2,303 Dare Bioscience shares in Q3 2015, an estimated $1.27M.
  • Clough Capital Partners first reported a position in Dare Bioscience in Q2 2015 and held it in 1 quarter.
  • Clough Capital Partners's Dare Bioscience position peaked at $1.27M in Q2 2015.
  • 38 funds tracked by Wall St. Rank held Dare Bioscience as of Q3 2015.

Based on Clough Capital Partners's 13F filing for Q3 2015, filed 16 Nov 2015.